Tarja Mälkönen

912 total citations
8 papers, 158 citations indexed

About

Tarja Mälkönen is a scholar working on Immunology, Dermatology and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Tarja Mälkönen has authored 8 papers receiving a total of 158 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Immunology, 5 papers in Dermatology and 3 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Tarja Mälkönen's work include Psoriasis: Treatment and Pathogenesis (4 papers), Pharmaceutical studies and practices (3 papers) and Health Systems, Economic Evaluations, Quality of Life (2 papers). Tarja Mälkönen is often cited by papers focused on Psoriasis: Treatment and Pathogenesis (4 papers), Pharmaceutical studies and practices (3 papers) and Health Systems, Economic Evaluations, Quality of Life (2 papers). Tarja Mälkönen collaborates with scholars based in Finland, Sweden and United Kingdom. Tarja Mälkönen's co-authors include Ritva Luukkonen, Kristiina Alanko, Riitta Jolanki, Kristiina Aalto‐Korte, Päivikki Susitaival, Antti Lauerma, Anne Puustinen, Harri Mustonen, Kaarina Heiskanen and Kaija‐Leena Kolho and has published in prestigious journals such as British Journal of Dermatology, Inflammatory Bowel Diseases and Value in Health.

In The Last Decade

Tarja Mälkönen

7 papers receiving 153 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Tarja Mälkönen Finland 5 100 48 48 35 34 8 158
Judit Lukács Germany 8 163 1.6× 49 1.0× 20 0.4× 33 0.9× 77 2.3× 13 284
Kanwaljit Brar United States 8 138 1.4× 103 2.1× 62 1.3× 13 0.4× 25 0.7× 30 245
Kerstin Taniguchi Abagge Brazil 10 104 1.0× 19 0.4× 21 0.4× 8 0.2× 38 1.1× 36 220
Esra Yücel Türkiye 7 32 0.3× 43 0.9× 22 0.5× 12 0.3× 16 0.5× 38 133
J.C. Armario-Hita Spain 11 209 2.1× 88 1.8× 15 0.3× 39 1.1× 47 1.4× 29 264
Maia Brewerton New Zealand 8 41 0.4× 104 2.2× 169 3.5× 11 0.3× 27 0.8× 15 303
Violeta Zaragozá Ninet Spain 6 71 0.7× 27 0.6× 17 0.4× 17 0.5× 41 1.2× 24 157
M. Blanes Spain 9 108 1.1× 8 0.2× 18 0.4× 19 0.5× 98 2.9× 36 219
Donald Stark Canada 6 35 0.3× 29 0.6× 91 1.9× 30 0.9× 38 1.1× 11 173
Justin D. Lu Canada 8 58 0.6× 11 0.2× 26 0.5× 44 1.3× 27 0.8× 22 169

Countries citing papers authored by Tarja Mälkönen

Since Specialization
Citations

This map shows the geographic impact of Tarja Mälkönen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tarja Mälkönen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tarja Mälkönen more than expected).

Fields of papers citing papers by Tarja Mälkönen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tarja Mälkönen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tarja Mälkönen. The network helps show where Tarja Mälkönen may publish in the future.

Co-authorship network of co-authors of Tarja Mälkönen

This figure shows the co-authorship network connecting the top 25 collaborators of Tarja Mälkönen. A scholar is included among the top collaborators of Tarja Mälkönen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tarja Mälkönen. Tarja Mälkönen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Ukkola‐Vuoti, Liisa, et al.. (2025). A population-based registry study on psoriasis-associated burden of disease in Finland. Frontiers in Medicine. 12. 1605100–1605100.
2.
Westerlund, Anna, Fabian Hoti, Jin‐Young Lee, et al.. (2024). Persistence of advanced systemic pharmacological treatment of moderate‐to‐severe psoriasis among bio‐naïve patients—A retrospective register‐based cohort study in Finland and Sweden. Journal of the European Academy of Dermatology and Venereology. 39(S1). 50–64. 2 indexed citations
3.
Väkevä, Liisa, Annamari Ranki, & Tarja Mälkönen. (2015). Intralesional Rituximab Treatment for Primary Cutaneous B-cell Lymphoma: Nine Finnish Cases. Acta Dermato Venereologica. 96(3). 396–397. 5 indexed citations
4.
Väätäinen, Saku, et al.. (2015). Cost-Effectiveness of Ustekinumab In The Treatment of Psoriasis In Finland. Value in Health. 18(7). A670–A670. 1 indexed citations
5.
Mälkönen, Tarja, Anne Puustinen, Kaarina Heiskanen, et al.. (2014). Skin Reactions During Anti-TNFα Therapy for Pediatric Inflammatory Bowel Disease. Inflammatory Bowel Diseases. 20(8). 1309–1315. 44 indexed citations
6.
Tuuminen, Tamara, Sari H. Pakkanen, Anu Kantele, et al.. (2012). Immunosuppression Adversely Affects TST but Not IGRAs in Patients with Psoriasis or Inflammatory Musculoskeletal Diseases. International Journal of Rheumatology. 2012. 1–8. 17 indexed citations
7.
Mälkönen, Tarja, Kristiina Alanko, Riitta Jolanki, et al.. (2010). Long-term follow-up study of occupational hand eczema. British Journal of Dermatology. 163(5). 999–1006. 66 indexed citations
8.
Mälkönen, Tarja, Riitta Jolanki, Kristiina Alanko, et al.. (2009). A 6‐month follow‐up study of 1048 patients diagnosed with an occupational skin disease. Contact Dermatitis. 61(5). 261–268. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026